IAN J. CLARK6595 Crest Top DriveWest Bloomfield, Michigan 48322H +1 (248) 926-5744C +1 (650) 868-8609 ijc1962@gmail.com

S U M M A R Y

A forward-thinking, results-driven, medical devices senior executive, with extensive global experience in medical affairs, market development, product development and surveillance, healthcare operations and compliance, customer care, co-marketing, sales & strategic alliance management across global markets. A consistently proven aptitude for integrating multiple internal and external requirements through the development of structured approaches and strong frameworks to address new and existing challenges through the use of unique solutions development and implementation; including outreach, advocacy and resource development for internal and external stakeholders in pursuit of goal performance. A competitive leader, with expertise in strategic and tactical management practices with a high level of cultural awareness and experience; policy & procedure development, implementation and management across a broad range of requirements and functions. A committed and detail-oriented top performer who positions his company as an industry front-runner and establishes strategies, tactics and processes for long-term growth.

E X P E R I E N C E

ABBOTT VASCULAR, Santa Clara, CaliforniaDirector, Professional Education, Medical Affairs, and Government Transparency, 2011-2015

Directed U.S. education grant strategies in line with internal stakeholders and compliance with external regulations. Developed, implemented, and maintained multiple division-level government transparency policy and procedures aligned to Abbott Laboratories corporate initiatives. Designed, developed, implemented and managed the expanded Medical Affairs Department.

Represented Abbott Laboratories device divisions at the global level as a founding and core member of executive transparency steering committee to establish company-wide, global policies and procedures with regard to reportable spending.

Implemented, formalized, and oversaw U.S. medical science and medical information teams to enable balanced scientific support and awareness of Abbott Vascular’s therapeutic areas.

Developed and managed medical information group to ensure compliant scientific responses to Abbott Vascular’s global client base.

Designed, developed, and implemented clinical training and support for Product Surveillance Department.

Expanded and enhanced key society and association relationships in conjunction with Abbott Vascular’s expanding portfolio presence and overall strategy.

Director, United States Sales Training and Medical Education, 2008-2011

Established, formalized, implemented and managed new-employee training for sales & marketing personnel and medical education for PMA-required education and key commercial initiatives in alignment with core strategies. in alignment with division strategy in line with company strategy Designed and implemented global training management process for sales personnel and Health Care Professionals (HCPs). Developed and managed accredited training for HCPs for training and education needs of Abbott Vascular’s product lines. Conceived, developed and managed key medical and professional society and association representation in conjunction with Abbott’s US strategies.

Integrated and managed physician and staff training program, including significant CEU courses for HCPs with 35 000 hours delivered per year.

Created and maintained responsibility for U.S. training, education, grant, and government transparency budgets.

Managed long-term product and field global training policy and approach, including the development and implementation of global training standards for Sales and Marketing

Developed, implemented and maintained, and U.S. education grant strategies in line with internal stakeholders and compliance with external regulations,

Developed implemented and maintained division-level government transparency policy and procedures in alignment with corporate initiatives.

Ian J. Clark, Page 2

Created and managed Abbott representation with key societies and associations with regard to company strategy, education policy, industry guidelines, existing and emerging legislation to ensure that company interests were appropriately represented and maintained.

Director, United States Endovascular Marketing, 2007-2008

Established, formalized, implemented and managed U.S. endovascular marketing strategy, including product development and rationalization strategies. Developed and oversaw field inventory and consolidation post Guidant acquisition. Created and maintained responsibility for U.S. marketing budgets.

Designed long-term product, sales and field representation strategy.

Launched and managed global responsibility matrices to ensure compliance with and responsibility for product manufacturing budgets and launch planning.

Instituted and maintained financial and performance reviews for U.S. endovascular sales.

Launched key new products (Starclose SE, Fox Balloons, Herculink Elite, Nav 6), resulting in significant market-share gains.

Developed and implemented U.S. field consignment process, reducing expiry losses by 75% (bottom-line profit improvement by >$5 000 000) and eliminating non-performing accounts (900 accounts eliminated in total).

Director, Global Strategic Marketing, Vessel Closure, Redwood City, California, 2006-2007

Established, formalized, and managed global device strategy for Vessel Closure (VC) Division. Developed and managed global physician strategic advisory boards to assist in the development and validation of global strategy. Coordinated business development activities at divisional and corporate level. Provided direction and guidance for regional market development and planning. Oversaw global P&L. Created and organized PR material for corporate quarterly earnings calls. Managed and instituted physician education, staff training programs, and internal and physician-initiated study strategies. Designed and provided oversight to product complaint process and FDA-reportable cases.

Developed or co-developed design concepts and numerous product enhancements resulting in the development and launch of the StarClose SE Vessel Closure Device (VCD).

Authored and co-authored multiple patents as part of the vessel closure device development strategy

Designed, developed and implemented programs to mentor, educate and train R&D engineers, as well as develop clinical skill set requirements, to further align clinical needs to product development.

Served as key clinical link to R&D for long-term product development.

Conceived and co-designed IP mapping process and strategy to develop “protected areas” of vessel closure devices.

Director, Global Strategic Alliances, 2005-2006

Developed, implemented and managed Abbott Vascular’s global strategy for the coordination of key physician relationships across all departments within the organization to ensure alignment with overall strategy. Conceived and developed criteria for key physicians to balance needs and requirements of corporate, clinical, R&D, and regional needs, ensuring full visibility in all physician contracts and relationships.

Designed, created, and managed Web-based system for management of key physician calendars, contract coordination, and cross-functional meeting summary.

Established and coordinated cross-functional contract approach to minimize duplication as well as to create consistency across organization. Achieving a significant reduction in contract duplication and enabling the rationalization and cost reduction of hiring external consultants.

Director, Asia, Australia, and Pacific, Sydney, Australia, 2002-2005

General Manager of regional office, distribution and direct sales teams, with full regional P&L ownership and responsibility. Developed and managed annual sales and P&L targets, including Australian (direct sales) and device reimbursement strategies and implementation. Created and implemented region-specific marketing plans and materials in support of commercial goals and targets for the Asia-Pacific/Australia/Japan region. Managed regulatory strategy and supervision. Oversaw the development and management of key customer relationships, including global and regional clinical trials for local, CE mark and FDA approvals.

Consistently achieved double-digit year-on-year sales growth in excess of regional plan targets.

Ian J. Clark, Page 3

Integrated three acquired companies into direct and distribution sales structure to achieve company’s commercial goals of developing and managing consistent product representation whilst reducing distribution costs and increasing overall profitability

A D D I T I O N A L E X P E R I E N C E

PERCLOSE INC., Sydney, Australia, Sales and Marketing Manager, Asia, Australia, and Pacific, 1999-2002. Oversaw market establishment and growth in Australian, Asian, and Japanese markets, with specific emphasis on un-served markets and creation of value-based models to allow for market entry of new products never sold within markets, including development of new distribution structure.

SCHNEIDER ASIA PACIFIC, Sydney, Australia, Senior Products Manager and Business Development Manager, 1997-1998. Product Manager and Business Development, 1993-1997. Managed Indian sales territory, achieving sales growth of 500% and market position from third supplier position to market leader. Coordinated device development with corporate R&D (Wallstent, Valvuloplasty Balloons, PTCA Balloons for Japan). International Product Specialist, 1992-1993.

NURSING – Numerous positions in Coronary Care, Post Cardiac Surgery, Cardiac Catheterization Laboratory – England & Australia

E D U C A T I O N

MANCHESTER ROYAL INFIRMARY, Manchester, EnglandR.G.N., 1989

MANCHESTER METROPOLITAN UNIVERSITY, Manchester, EnglandB.Sc., (Hons.) Geography and Environmental Science, 1985

P A T E N T S

Issued

8858594 - Curved Closure Device - October 20148657852 - Closure Device - February 20148398676 - Closure Device - March 20138323312 - Closure Device - December 2012822681 - Methods, device, and Apparatus for Managing Access through Tissue - July 20127993303 - Stiffening Support Catheter and Methods for Using Same - August 2011

Pending Applications

20130190810 - Closure Device20110054492 - Medical Device for Repairing a Fistula20100168790 - Curved Closure Device

P R O F E S S I O N A L D E V E L O P M E N T

Professional Selling Skills I and II

Train the Trainer

Abbott’s Global Leadership Training

Negotiation Skills

Australian Business Management Sales Training, Basic and Advanced

Presentation Skills

Vantage Partners Negotiation Skills

Abbott's Compass Program – Abbott Laboratories fast-track executive development program

Abbott's Strategic Thinking Course

Ian J. Clark, Page 4

P R O F E S S I O N A L A S S O C I A T I O N M E M B E R S H I P

Consultant Member of Society of Coronary Angiography and Intervention

Editorial Board Member – Life Science Compliance Update

AdvaMed – including development of revised code of conduct and the development of best practice guidelines.

P R O F E S S I O N A L S P E A K I N G E N G A G E M E N T S

Vascular StentingPTCA and PTAEndovascular Management of Biliary DiseaseVessel Closure ComplicationsDevelopment of Aggregate Spend SolutionsImpact of Sunshine Act on Health Care ProfessionalsKey Opinion Leader Engagement (Keynote speaker)

R E F E R E N C E S

Available upon request